Physician-led weight loss
GLP-1 receptor agonists are a clinically studied class of medications that can help with weight management when prescribed as part of a comprehensive treatment plan overseen by a licensed physician.
Important Notice
GLP-1 medications are prescription-only and require a clinical evaluation by a licensed physician. Not everyone is a candidate. Individual results vary. View full safety information
What are GLP-1 medications?
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic a naturally occurring hormone in your body. Originally developed for the management of type 2 diabetes, these medications have been clinically studied and shown to support weight management in eligible individuals.
GLP-1 medications work by activating receptors in the brain that help regulate appetite and food intake. They may help reduce hunger, increase feelings of fullness, and slow gastric emptying — all of which can contribute to weight reduction when combined with lifestyle modifications.
At Orik Health, a licensed physician evaluates your medical history, current health status, and weight loss goals to determine if GLP-1 therapy is clinically appropriate for you. Treatment is always individualized and monitored by your care team.
Important Safety Information
GLP-1 receptor agonists are prescription medications. They are not appropriate for everyone. A licensed physician must evaluate your medical history and determine if this treatment is right for you.
Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. These side effects are generally mild to moderate and tend to improve over time.
Serious side effects may include pancreatitis, gallbladder problems, kidney problems, allergic reactions, increased heart rate, and changes in vision in patients with type 2 diabetes. Seek immediate medical attention if you experience severe abdominal pain, signs of allergic reaction, or other concerning symptoms.
Contraindications: GLP-1 medications should not be used by patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). They are not recommended during pregnancy or breastfeeding.
Individual results vary. Orik Health does not guarantee specific weight loss outcomes. Compounded medications, when prescribed, have not been reviewed or approved by the FDA for safety or effectiveness.